Early Fostamatinib Use Shows High Response Rates in Immune Thrombocytopenia
A nationwide Spanish real-world study of 72 adults with immune thrombocytopenia found that fostamatinib, an oral spleen tyrosine kinase inhibitor, ...
A nationwide Spanish real-world study of 72 adults with immune thrombocytopenia found that fostamatinib, an oral spleen tyrosine kinase inhibitor, ...
A pooled analysis of US and Canadian birth cohorts finds that children starting montelukast for asthma face significantly higher risks ...
Penn State researchers show that prewetting sterilizing-grade membranes with polysorbate 20 can boost nanoemulsion filtration capacity more than 100-fold, improving ...
A large pharmacovigilance analysis of over 30,000 adverse event reports confirms riociguat's known risks and uncovers new safety signals, including ...
A pharmacovigilance analysis of US and Japanese adverse event databases finds that PD-1 and PD-L1 checkpoint inhibitors show a robust, ...
The first systematic safety evaluation of the choleretic drug mefepronic acid in sheep found no clinical adverse effects and stable ...
A retrospective study of 16 Chinese children with persistent or chronic immune thrombocytopenia finds that romiplostim is safe but provides ...
A large prospective Japanese study found that late-line treatment sequences beginning with either regorafenib or trifluridine/tipiracil plus bevacizumab yielded comparable ...
A large real-world analysis of TriNetX health records finds that mirvetuximab soravtansine carries elevated risks of corneal toxicity and peripheral ...
A retrospective study at Peking University People's Hospital found that adding all-trans retinoic acid to thrombopoietin receptor agonists restored platelet ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine